List of works - M Chekenya

3D image texture analysis of simulated and real-world vascular trees.

scientific article published on 30 July 2011

A reproducible brain tumour model established from human glioblastoma biopsies

scientific article

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

scientific article

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

scientific article published on January 2014

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma

scientific article

Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model

scientific article

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation

scientific article

Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients.

scientific article published on 12 July 2016

Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients.

scientific article published on 5 June 2017

NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours.

scientific article published on July 2002

NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation.

scientific article published on 22 February 2008

NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.

scientific article

Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours

scientific article published on 02 October 2013

Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence-activated cell sorting.

scientific article published on November 2010

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival

scientific article published on 17 July 2019

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

scientific article published on 24 June 2020

The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.

scientific article published on October 2002

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

scientific article published on 29 April 2015

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells

scientific article

List of works by M Chekenya

3D image texture analysis of simulated and real-world vascular trees.

A reproducible brain tumour model established from human glioblastoma biopsies

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma

Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a human GBM xenograft model

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation

Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients.

Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients.

NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours.

NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation.

NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.

Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours

Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence-activated cell sorting.

Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study

The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.

Therapeutic potential and challenges of natural killer cells in treatment of solid tumors

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells